Research
Although scientists at the University of Nebraska Medical Center have been researching cancer since the early 1960s, the national crusade against cancer was mobilized in 1971 when President Richard Nixon signed the National Cancer Act. Over the past quarter century, remarkable advances in cancer research have been attained. In 1996, the National Cancer Institute reported that the cancer death rate in the United States has peaked and, for the first time, begun to fall. This accomplishment comes as a result of the knowledge gained in laboratories and used by scientists and clinicians to develop improved prevention, early detection and diagnosis and treatment strategies.
Despite the tremendous headway made in understanding the biological and chemical processes that cause cancer cells to develop, the search for a cure continues. At the UNMC Eppley Cancer Center, researchers are developing creative research tools to unlock the secrets of this complex disease and devise optimal prevention and treatment strategies.
Research Programs
|
Program Name
|
Program Leader(s) |
|
|
Molecular Biochemical Etiology Program (MBEP)
–
Researchers in this program stimulate collaborative
multidisciplinary research to further our understanding of
the molecular and biochemical events leading to oncogenesis
and to develop strategies for abrogating these events. |
James Shull, PhD
Chair of the Department of Genetics, Cell Biology and
Anatomy 402-559-4633 |
|
|
Hamid Band, PhD Eppley Cancer Center Associate Director for Education and Training 402-559- hband@unmc.edu |
||
|
Cancer Genes and Molecular Regulation Program
(CGMRP)
– Members in this program study the mechanisms that cause cells
to become malignant and form tumors. |
Robert Lewis, Ph.D.
Professor
Eppley Institute for Research in Cancer and Allied Diseases
402-559-8290
|
|
|
Jean Grem, MD |
||
|
Lymphoma Research Program (LRP) –
Research in this program is focused on identifying causes,
evaluation of molecular markers of prognosis, and
development of new therapies for hematological malignancies.
|
Wing Chung (John) Chan, MD
Professor
Pathology and Microbiology
402-559-7684
|
|
|
Julie Vose, MD
Chair of the Oncology/Hematology Section
402-559-3848
|
||
|
Cancer Prevention and Control Program (CPCP)
–
Members in this developing program focus on improving the
current knowledge base for promoting overall reductions in
cancer incidence,
morbidity, and mortality, as well as conducting research on
reducing
cancer risk and
incidence,
reducing complications secondary to cancer,
managing
symptoms and
improving quality of life and survivorship.
|
Ann M. Berger, PhD, RN, AOCN, FAAN
Professor
402-559-4957
|
|
|
Shinobu Watanabe-Galloway, PhD
Assistant Professor
402-559-5387
|
||
